What does a Prostate-Specific Antigen (PSA) test show?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A Prostate-Specific Antigen (PSA) test shows the level of PSA in a man's blood, which can help detect prostate cancer early, as well as provide information about other prostate conditions, but it is not definitive for cancer diagnosis on its own. The test measures the level of PSA, a protein produced by both cancerous and noncancerous tissue in the prostate gland 1. Normal PSA levels typically range from 0 to 4 nanograms per milliliter (ng/mL), though this can vary by age. Higher PSA levels may indicate prostate cancer, but can also result from benign conditions like prostatitis (inflammation of the prostate), benign prostatic hyperplasia (enlarged prostate), or recent ejaculation.

Some key points to consider when interpreting PSA test results include:

  • The sensitivity and specificity of PSA levels for detecting any prostate cancer, with a sensitivity of about 32% and a specificity of about 87% at a cut-off of 3.1 ng/mL 1
  • The fact that only about 25% of men with PSA in the 4 to 10 ng/mL range have a subsequent positive biopsy 1
  • The importance of monitoring PSA levels over time to detect concerning trends, rather than relying on a single test result 1
  • The use of PSA testing in combination with other diagnostic tools, such as digital rectal exams or prostate biopsies, to improve the accuracy of prostate cancer diagnosis 1

It's also important to note that PSA testing is generally recommended for men over 50, or earlier for those with risk factors such as family history or African American ethnicity 1. The test requires a simple blood draw and no special preparation, making it a convenient screening tool despite its limitations in specificity. Overall, a PSA test is a useful tool for detecting prostate cancer early, but it should be used in conjunction with other diagnostic tools and interpreted in the context of a man's individual risk factors and medical history.

From the Research

What does a PSA test show

  • A Prostate-Specific Antigen (PSA) test measures the level of PSA in a man's blood, which can be elevated in men with prostatic disease, including cancer 2.
  • The test is not cancer-specific and can be elevated due to other conditions such as prostatitis, benign prostatic hypertrophy, and other non-cancerous conditions 3.
  • A PSA test can show:
    • Elevated PSA levels, which may indicate prostate cancer, but can also be caused by other conditions 4.
    • The level of PSA in the blood, which can be used to monitor disease progression or recurrence, but absolute levels are rarely meaningful 3.
    • Changes in PSA levels over time, which can provide insight into the presence of prostate cancer, but not definitive proof 3.

Limitations of PSA testing

  • PSA testing has limitations, including a high frequency of falsely elevated values in men with benign prostatic hyperplasia (BPH) 4.
  • The test can be affected by hormonal control, drug therapy, stage of disease, and genetic factors, which can lead to varying PSA levels in different men 3.
  • PSA determination should be obtained after complete clinical resolution of inflammation to exclude prostatic malignant involvement 5.

Comparison with other markers

  • PSA has been compared to other markers, such as prostatic acid phosphatase (PAP), and has been found to be more sensitive for detecting prostate cancer 6.
  • The combination of PSA and PAP may serve as a useful adjunct for differential diagnosis and confirmation of advanced stage prostate cancer 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Role of prostate-specific antigen and digital rectal examination in the detection of prostate cancer.

International journal of urology : official journal of the Japanese Urological Association, 1994

Research

Prostate-specific antigen.

Seminars in cancer biology, 1999

Research

Prostate-specific antigen levels in acute and chronic bacterial prostatitis.

Hinyokika kiyo. Acta urologica Japonica, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.